secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ernexa Therapeutics Inc. (ERNA)
CIK:        0000748592
Form:       8-K
Filed at:   2024-09-25T23:59:59+00:00
Accession:  0001493152-24-038129
Event type: debt
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 2.03, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Eterna raises $3.9M via 12% notes; proposes debt/warrant exchange for 38.3M shares
--------------------------------------------------------------------------------

- Closed $3.9M 12.0% senior convertible note private placement; net proceeds for general corporate purposes.
- Agreed to sell 1,516,997 shares at $0.75/share for $1.1M in a separate common stock private placement.
- Proposes to exchange outstanding convertible notes and warrants for ~38.3M shares, subject to stockholder approval.
- Annual meeting postponed from Sept 27 to Oct 29, 2024; stockholder proposals due Oct 5.
- Support agreements covering ~48% of outstanding shares commit to vote in favor of stockholder approval.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/748592/000149315224038129/0001493152-24-038129-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/748592/000149315224038129/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-038129

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer